31 related articles for article (PubMed ID: 19373033)
1. HIV protease inhibitors in pregnancy : pharmacology and clinical use.
Andany N; Loutfy MR
Drugs; 2013 Mar; 73(3):229-47. PubMed ID: 23404092
[TBL] [Abstract][Full Text] [Related]
2. Improved oral bioavailability of lopinavir in melt-extruded tablet formulation reduces impact of third trimester on lopinavir plasma concentrations.
Else LJ; Douglas M; Dickinson L; Back DJ; Khoo SH; Taylor GP
Antimicrob Agents Chemother; 2012 Feb; 56(2):816-24. PubMed ID: 22106215
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings.
Peterson K; Jallow S; Rowland-Jones SL; de Silva TI
AIDS Res Treat; 2011; 2011():463704. PubMed ID: 21490779
[TBL] [Abstract][Full Text] [Related]
4. Immune activation mediated change in alpha-1-acid glycoprotein: impact on total and free lopinavir plasma exposure.
Ofotokun I; Lennox JL; Eaton ME; Ritchie JC; Easley KA; Masalovich SE; Long MC; Acosta EP
J Clin Pharmacol; 2011 Nov; 51(11):1539-48. PubMed ID: 21209245
[TBL] [Abstract][Full Text] [Related]
5. An update on HIV-1 antiretroviral resistance.
Plank RM; Kuritzkes DR
Curr Opin HIV AIDS; 2006 Sep; 1(5):417-23. PubMed ID: 19372841
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics, safety and efficacy of boosted saquinavir tablets in HIV type-1-infected pregnant women.
van der Lugt J; Colbers A; Molto J; Hawkins D; van der Ende M; Vogel M; Wyen C; Schutz M; Koopmans P; Ruxrungtham K; Richter C; Burger D;
Antivir Ther; 2009; 14(3):443-50. PubMed ID: 19474478
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacology of HIV protease inhibitors in pregnancy.
van der Lugt J; Colbers A; Burger D
Curr Opin HIV AIDS; 2008 Nov; 3(6):620-6. PubMed ID: 19373033
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
Justesen US
Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
[TBL] [Abstract][Full Text] [Related]
10. Saquinavir, the pioneer antiretroviral protease inhibitor.
la Porte CJ
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1313-22. PubMed ID: 19737048
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
